| Product Code: ETC7270898 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia Prophylactic Vaccines Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Gambia Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Gambia Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Gambia Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Gambia Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Gambia Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Gambia Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Gambia Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Gambia Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing diseases. |
4.2.2 Growing government initiatives to promote vaccination programs. |
4.2.3 Rising prevalence of infectious diseases in the Gambia. |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas. |
4.3.2 High costs associated with vaccine procurement and distribution. |
4.3.3 Lack of proper storage and cold chain infrastructure. |
5 Gambia Prophylactic Vaccines Market Trends |
6 Gambia Prophylactic Vaccines Market, By Types |
6.1 Gambia Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Gambia Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Gambia Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Gambia Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Gambia Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Gambia Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Gambia Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Gambia Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Gambia Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Gambia Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Gambia Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Gambia Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Gambia Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Gambia Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Gambia Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Gambia Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Gambia Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Gambia Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Gambia Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Gambia Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Gambia Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Gambia Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Gambia Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Gambia Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Gambia Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Gambia Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Gambia Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Gambia Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Gambia Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Gambia Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Gambia Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Gambia Prophylactic Vaccines Market Export to Major Countries |
7.2 Gambia Prophylactic Vaccines Market Imports from Major Countries |
8 Gambia Prophylactic Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate among target population. |
8.2 Number of vaccination campaigns conducted annually. |
8.3 Percentage of healthcare workers trained in vaccine administration. |
8.4 Rate of vaccine wastage due to improper storage or handling. |
8.5 Number of reported cases of vaccine-preventable diseases in the Gambia. |
9 Gambia Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Gambia Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Gambia Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Gambia Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Gambia Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Gambia Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Gambia Prophylactic Vaccines Market - Competitive Landscape |
10.1 Gambia Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Gambia Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here